Veljanoski v. Juno Therapeutics, Inc. et al
Filing
108
STIPULATED PROTECTIVE ORDER signed by Judge Ricardo S Martinez. (PM)
1
2
3
4
5
6
UNITED STATES DISTRICT COURT
7
WESTERN DISTRICT OF WASHINGTON
AT SEATTLE
8
9
CASE NO.: C16-1069 RSM
10
11
STIPULATED PROTECTIVE
ORDER
12
13
In re JUNO THERAPEUTICS, INC.
14
15
16
17
18
19
20
21
22
23
24
25
26
27
STIPULATED PROTECTIVE ORDER
NO. C16-1069 RSM
CRAVATH, SWAINE AND MOORE LLP
825 Eighth Avenue, New York, NY 10019-7475
Tel: (212) 474-1000 • Fax: (212) 474-3700
1
In connection with the production of confidential documents and other confidential
2
information in this action, Plaintiffs Gilbert Hoang Nguyen and Susan Tan and Defendants Juno
3
Therapeutics, Inc. (“Juno”), Hans E. Bishop, Steven D. Harr, and Mark J. Gilbert, through their
4
respective counsel, enter into this Stipulated Protective Order for the Treatment of Designated
5
Information.
6
1.
PURPOSES AND LIMITATIONS
7
Discovery in this action is likely to involve production of confidential, proprietary, or
8
private information for which special protection may be warranted. Accordingly, the parties hereby
9
stipulate to and petition the Court to enter the following Stipulated Protective Order. The purpose
10
of this Stipulated Protective Order is to provide a means for limiting access to, use, and disclosure
11
of confidential material (as defined below) produced in this action while affording public
12
disclosure to the greatest extent possible. The parties acknowledge that this agreement is consistent
13
with LCR 26(c). It does not confer blanket protection on all disclosures or responses to discovery,
14
the protection it affords from public disclosure and use extends only to the limited information or
15
items that are entitled to confidential treatment under the applicable legal principles, and it does
16
not presumptively entitle parties to file confidential material (as defined below) under seal.
17
2.
18
19
20
“CONFIDENTIAL” MATERIAL
“Confidential” material shall include the following documents, deposition testimony,
information, and other tangible or intangible items produced or otherwise exchanged:
(i)
non-public intellectual property or proprietary information, including, but
21
not limited to, research, data, technical specifications, designs, processes, production methods,
22
cost or pricing regarding any Juno product, or any communications concerning the foregoing;
23
24
25
26
27
(ii)
non-public communications concerning development, testing, or analyses
of pre-clinical and clinical-stage pharmaceutical products;
(iii)
non-public communications with any governmental regulatory or
supervisory agency, body or group;
(iv)
non-public clinical study data and analyses;
STIPULATED PROTECTIVE ORDER
NO. C16-1069 RSM
-1-
CRAVATH, SWAINE AND MOORE LLP
825 Eighth Avenue, New York, NY 10019-7475
Tel: (212) 474-1000 • Fax: (212) 474-3700
(v)
1
non-public information pertaining or referring to Juno’s regulatory,
2
financial, business development or marketing plans or practices that, if disclosed, could damage
3
Juno’s competitive position;
(vi)
4
non-public information obtained from a non-party pursuant to a non-
5
disclosure agreement, or that the producing party is under a legal or contractual obligation to
6
maintain as confidential;
7
(vii)
non-public personal, medical or financial information; or
8
(viii)
non-public terms of commercial agreements, licensing agreements,
9
collaboration agreements, clinical trial agreements, sponsored research agreements, settlement
10
agreements or communications pertaining to such agreements.
11
3.
SCOPE
12
The protections conferred by this agreement cover not only confidential material (as
13
defined above), but also (1) any information copied or extracted from confidential material; (2) all
14
copies, excerpts, summaries, or compilations of confidential material; and (3) any testimony,
15
conversations, or presentations by parties or their counsel that might reveal confidential material.
16
However, the protections conferred by this agreement do not cover information that is in
17
the public domain or becomes part of the public domain through trial or otherwise.
18
4.
19
ACCESS TO AND USE OF CONFIDENTIAL MATERIAL
4.1
Basic Principles. A receiving party may use confidential material that is disclosed
20
or produced by another party or by a non-party in connection with this case only for prosecuting,
21
defending, or attempting to settle this litigation. Confidential material may be disclosed only to
22
the categories of persons and under the conditions described in this agreement. Confidential
23
material must be stored and maintained by a receiving party at a location and in a secure manner
24
that ensures that access is limited to the persons authorized under this agreement.
25
4.2
Disclosure of “CONFIDENTIAL” Material. Unless otherwise ordered by the Court
26
or permitted in writing by the designating party, a receiving party may disclose confidential
27
material only to:
STIPULATED PROTECTIVE ORDER
NO. C16-1069 RSM
-2-
CRAVATH, SWAINE AND MOORE LLP
825 Eighth Avenue, New York, NY 10019-7475
Tel: (212) 474-1000 • Fax: (212) 474-3700
(a)
1
2
of counsel to whom it is reasonably necessary to disclose the information for this litigation;
(b)
3
4
the officers, directors, and employees (including in-house counsel) of the
receiving party to whom disclosure is reasonably necessary for this litigation;
(c)
5
6
the receiving party’s counsel of record in this action, as well as employees
experts and consultants to whom disclosure is reasonably necessary for this
litigation and who have signed the “Acknowledgment and Agreement to Be Bound” (Exhibit A);
7
(d)
the Court, court personnel, and court reporters and their staff;
8
(e)
copy or imaging services retained by counsel to assist in the duplication of
9
confidential material, provided that counsel for the party retaining the copy or imaging service
10
instructs the service not to disclose any confidential material to third parties and to immediately
11
return all originals and copies of any confidential material;
(f)
12
during their depositions, any witness to whom disclosure is reasonably
13
necessary who is not otherwise permitted to view confidential material pursuant to this agreement
14
and who has signed the “Acknowledgment and Agreement to Be Bound” (Exhibit A), unless
15
otherwise agreed by the designating party or ordered by the Court. Pages of transcribed deposition
16
testimony or exhibits to depositions that reveal confidential material must be separately bound by
17
the court reporter and may not be disclosed to anyone except as permitted under this agreement;
(g)
18
19
the author or recipient of a document containing the information or a
custodian or other person who otherwise possessed or knew the information; or
(h)
20
any mediator who the parties agree to use in the event the parties pursue
21
mediation, and any such mediator’s employees to whom disclosure is reasonably necessary for the
22
mediation.
23
4.3
Filing Confidential Material. Before filing confidential material or discussing or
24
referencing such material in court filings, the filing party shall confer with the designating party
25
to determine whether the designating party will remove the confidential designation, whether the
26
document can be redacted, or whether a motion to seal or stipulation and proposed order is
27
STIPULATED PROTECTIVE ORDER
NO. C16-1069 RSM
-3-
CRAVATH, SWAINE AND MOORE LLP
825 Eighth Avenue, New York, NY 10019-7475
Tel: (212) 474-1000 • Fax: (212) 474-3700
1
warranted. Local Civil Rule 5(g) sets forth the procedures that must be followed and the standards
2
that will be applied when a party seeks permission from the Court to file material under seal.
3
5.
4
DESIGNATING PROTECTED MATERIAL
5.1
Exercise of Restraint and Care in Designating Material for Protection. Each party
5
or non-party that designates information or items for protection under this agreement must take
6
care to limit any such designation to specific material that qualifies under the appropriate
7
standards. The designating party must designate for protection only those parts of material,
8
documents, items, or oral or written communications that qualify, so that other portions of the
9
material, documents, items, or communications for which protection is not warranted are not swept
10
unjustifiably within the ambit of this agreement.
11
Mass, indiscriminate, or routinized designations are prohibited. Designations that are
12
shown to be clearly unjustified or that have been made for an improper purpose (e.g., to
13
unnecessarily encumber or delay the case development process or to impose unnecessary expenses
14
and burdens on other parties) expose the designating party to sanctions.
15
If it comes to a designating party’s attention that information or items that it designated for
16
protection do not qualify for protection, the designating party must promptly notify all other parties
17
that it is withdrawing the mistaken designation.
18
5.2
Manner and Timing of Designations. Except as otherwise provided in this
19
agreement (see, e.g., section 5.2(a)), or as otherwise stipulated or ordered, disclosure or discovery
20
material that qualifies for protection under this agreement must be clearly so designated before or
21
when the material is disclosed or produced.
22
(a)
Information in documentary form: (e.g., paper or electronic documents and
23
deposition exhibits, but excluding transcripts of depositions or other pretrial or trial proceedings)
24
the designating party must affix the word “CONFIDENTIAL” to each page that contains
25
confidential material. If only a portion or portions of the material on a page qualifies for protection,
26
the producing party also must clearly identify the protected portion(s) (e.g., by making appropriate
27
markings in the margins).
STIPULATED PROTECTIVE ORDER
NO. C16-1069 RSM
-4-
CRAVATH, SWAINE AND MOORE LLP
825 Eighth Avenue, New York, NY 10019-7475
Tel: (212) 474-1000 • Fax: (212) 474-3700
(b)
1
Testimony given in deposition or in other pretrial proceedings: the parties
2
and any participating non-parties must identify on the record, during the deposition or other pretrial
3
proceeding, all protected testimony, without prejudice to their right to so designate other testimony
4
after reviewing the transcript. Any party or non-party may, within fifteen days after receiving the
5
transcript of the deposition or other pretrial proceeding, designate portions of the transcript, or
6
exhibits thereto, as confidential. If a party or non-party desires to protect confidential material at
7
trial, the issue should be addressed during the pre-trial conference.
(c)
8
Other tangible items: the producing party must affix in a prominent place
9
on the exterior of the container or containers in which the information or item is stored the word
10
“CONFIDENTIAL.” If only a portion or portions of the information or item warrant protection,
11
the producing party, to the extent practicable, shall identify the protected portion(s).
5.3
12
Inadvertent Failures to Designate. If timely corrected, an inadvertent failure to
13
designate qualified information or items does not, standing alone, waive the designating party’s
14
right to secure protection under this agreement for such material. Upon timely correction of a
15
designation, the receiving party must make reasonable efforts to ensure that the material is treated
16
in accordance with the provisions of this agreement.
17
6.
18
CHALLENGING CONFIDENTIALITY DESIGNATIONS
6.1
Timing of Challenges. Any party or non-party may challenge a designation of
19
confidentiality at any time. Unless a prompt challenge to a designating party’s confidentiality
20
designation is necessary to avoid foreseeable, substantial unfairness, unnecessary economic
21
burdens, or a significant disruption or delay of the litigation, a party does not waive its right to
22
challenge a confidentiality designation by electing not to mount a challenge promptly after the
23
original designation is disclosed.
24
6.2
Meet and Confer. The parties must make every attempt to resolve any dispute
25
regarding confidential designations without court involvement. Any motion regarding confidential
26
designations or for a protective order must include a certification, in the motion or in a declaration
27
or affidavit, that the movant has engaged in a good faith meet and confer conference with other
STIPULATED PROTECTIVE ORDER
NO. C16-1069 RSM
-5-
CRAVATH, SWAINE AND MOORE LLP
825 Eighth Avenue, New York, NY 10019-7475
Tel: (212) 474-1000 • Fax: (212) 474-3700
1
affected parties in an effort to resolve the dispute without court action. The certification must list
2
the date, manner, and participants to the conference. A good faith effort to confer requires a face-
3
to-face meeting or a telephone conference.
6.3
4
Judicial Intervention. If the parties cannot resolve a challenge without court
5
intervention, the designating party may file and serve a motion to retain confidentiality under Local
6
Civil Rule 7 (and in compliance with Local Civil Rule 5(g), if applicable). The burden of
7
persuasion in any such motion shall be on the designating party. Frivolous challenges, and those
8
made for an improper purpose (e.g., to harass or impose unnecessary expenses and burdens on
9
other parties) may expose the challenging party to sanctions. All parties shall continue to maintain
10
the material in question as confidential until the Court rules on the challenge.
11
7.
12
If a party is served with a subpoena or a court order issued in other litigation that compels
13
14
15
disclosure of any information or items designated in this action as “CONFIDENTIAL,” that party
must:
(a)
16
17
20
(b)
23
24
25
26
27
promptly notify in writing the party who caused the subpoena or order to
issue in the other litigation that some or all of the material covered by the subpoena or order is
subject to this agreement. Such notification shall include a copy of this agreement; and
(c)
21
22
promptly notify the designating party in writing and include a copy of the
subpoena or court order;
18
19
PROTECTED MATERIAL SUBPOENAED OR ORDERED PRODUCED IN
OTHER LITIGATION
cooperate with respect to all reasonable procedures sought to be pursued by
the designating party whose confidential material may be affected.
8.
UNAUTHORIZED DISCLOSURE OF PROTECTED MATERIAL
If a receiving party learns that, by inadvertence or otherwise, it has disclosed confidential
material to any person or in any circumstance not authorized under this agreement, the receiving
party must immediately (a) notify in writing the designating party of the unauthorized disclosures,
(b) use its best efforts to retrieve all unauthorized copies of the protected material, (c) inform the
STIPULATED PROTECTIVE ORDER
NO. C16-1069 RSM
-6-
CRAVATH, SWAINE AND MOORE LLP
825 Eighth Avenue, New York, NY 10019-7475
Tel: (212) 474-1000 • Fax: (212) 474-3700
1
person or persons to whom unauthorized disclosures were made of all the terms of this agreement,
2
and (d) request that such person or persons execute the “Acknowledgment and Agreement to Be
3
Bound” that is attached hereto as Exhibit A.
4
9.
5
8
9
10
11
12
13
14
15
16
17
18
19
20
OF
PRIVILEGED
OR
OTHERWISE
When a producing party gives notice to receiving parties that certain inadvertently
6
7
INADVERTENT PRODUCTION
PROTECTED MATERIAL
produced material is subject to a claim of privilege or other protection, the obligations of the
receiving parties are those set forth in Federal Rule of Civil Procedure 26(b)(5)(B). This provision
does not, however, alter the provisions of the parties’ Stipulation Regarding Discovery of
Electronically Stored Information. The parties agree to the entry of a non-waiver order under Fed.
R. Evid. 502(d) as set forth herein.
10.
NON TERMINATION AND RETURN OF DOCUMENTS
Within 60 days after the termination of this action, including all appeals, each receiving
party must either return or destroy all confidential material to the producing party, including all
copies, extracts, and summaries thereof. Notwithstanding this provision, counsel are entitled to
retain one archival copy of all documents filed with the Court; trial, deposition, and hearing
transcripts; correspondence; deposition and trial exhibits; expert reports; attorney work product;
and consultant and expert work product, even if such materials contain confidential material.
The confidentiality obligations imposed by this agreement shall remain in effect until a
designating party agrees otherwise in writing or a court orders otherwise.
21
22
23
IT IS SO STIPULATED, THROUGH COUNSEL OF RECORD.
DATED: November 30, 2017
s/ Omar Jafri
Attorneys for Plaintiff
DATED: November 30, 2017
s/ Lauren Rosenberg
Attorneys for Defendant
24
25
26
27
PURSUANT TO STIPULATION, IT IS SO ORDERED.
STIPULATED PROTECTIVE ORDER
NO. C16-1069 RSM
-7-
CRAVATH, SWAINE AND MOORE LLP
825 Eighth Avenue, New York, NY 10019-7475
Tel: (212) 474-1000 • Fax: (212) 474-3700
1
IT IS FURTHER ORDERED that pursuant to Fed. R. Evid. 502(d), the production of any
2
documents in this proceeding shall not, for the purposes of this proceeding or any other proceeding
3
in any other court, constitute a waiver by the producing party of any privilege applicable to those
4
documents, including the attorney-client privilege, attorney work-product protection, or any other
5
privilege or protection recognized by law.
6
7
DATED: December 18, 2017
8
9
A
10
RICARDO S. MARTINEZ
CHIEF UNITED STATES DISTRICT JUDGE
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
STIPULATED PROTECTIVE ORDER
NO. C16-1069 RSM
-8-
CRAVATH, SWAINE AND MOORE LLP
825 Eighth Avenue, New York, NY 10019-7475
Tel: (212) 474-1000 • Fax: (212) 474-3700
1
EXHIBIT A
2
ACKNOWLEDGMENT AND AGREEMENT TO BE BOUND
3
I,
____________________________________
[print
or
type
full
name],
of
4
____________________________________ [print or type full address], declare under penalty of
5
perjury that I have read in its entirety and understand the Stipulated Protective Order that was
6
issued by the United States District Court for the Western District of Washington on [date] in the
7
case of In re Juno Therapeutics, Inc., No. C16-1069 RSM. I agree to comply with and to be bound
8
by all the terms of this Stipulated Protective Order and I understand and acknowledge that failure
9
to so comply could expose me to sanctions and punishment in the nature of contempt. I solemnly
10
promise that I will not disclose in any manner any information or item that is subject to this
11
Stipulated Protective Order to any person or entity except in strict compliance with the provisions
12
of this Order.
13
I further agree to submit to the jurisdiction of the United States District Court for the
14
Western District of Washington for the purpose of enforcing the terms of this Stipulated Protective
15
Order, even if such enforcement proceedings occur after termination of this action.
16
Date:
17
City and State where sworn and signed:
18
Printed name:
19
Signature:
20
21
22
23
24
25
26
27
STIPULATED PROTECTIVE ORDER
NO. C16-1069 RSM
-9-
CRAVATH, SWAINE AND MOORE LLP
825 Eighth Avenue, New York, NY 10019-7475
Tel: (212) 474-1000 • Fax: (212) 474-3700
1
Dated: November 30, 2017
2
3
4
5
s/ Gregory L. Watts
Gregory L. Watts, WSBA #43995
WILSON SONSINI GOODRICH & ROSATI, PC
701 Fifth Avenue, Suite 5100
Seattle, Washington 98104
Tel:
(206) 883-2500
Fax:
(206) 883-2699
gwatts@wsgr.com
Nina F. Locker, pro hac vice
Ignacio E. Salceda, pro hac vice
Joni Ostler, pro hac vice
650 Page Mill Road
Palo Alto, CA 94304
Tel: (650) 849-3457
Fax: (650) 493-6811
nlocker@wsgr.com
isalceda@wsgr.com
jostler@wsgr.com
6
7
8
9
10
11
Daniel Slifkin
Karin A. DeMasi
Lauren M. Rosenberg
CRAVATH, SWAINE & MOORE LLP
825 Eighth Avenue
New York, NY 10019
Tel: (212) 474-1000
Fax: (212) 474-3700
dslifkin@cravath.com
kdemasi@cravath.com
lrosenberg@cravath.com
12
13
14
15
16
17
Attorney for Defendants Juno Therapeutics,
Inc., Hans E. Bishop, Steven D. Harr, and
Mark J. Gilbert
18
19
20
s/ Cliff
Cantor
21
22
By: Cliff Cantor, WSBA # 17893
LAW OFFICES OF CLIFFORD A.
CANTOR, P.C.
627 208th Ave. SE
Sammamish, WA 98074
Tel: (425) 868-7813
Fax: (425) 732-3752
cliff.cantor@outlook.com
Plaintiffs’ Liaison Counsel
23
24
25
26
27
STIPULATED PROTECTIVE ORDER
NO. C16-1069 RSM
-10-
CRAVATH, SWAINE AND MOORE LLP
825 Eighth Avenue, New York, NY 10019-7475
Tel: (212) 474-1000 • Fax: (212) 474-3700
1
POMERANTZ LLP
Patrick V. Dahlstrom
Leigh H. Smollar
Omar Jafri
Ten South La Salle Street, Suite 3505
Chicago, Illinois 60603
Tel: (312) 377-1181
Fax: (312) 377-1184
pdahlstrom@pomlaw.com
lsmollar@pomlaw.com
ojafri@pomlaw.com
2
3
4
5
6
7
8
POMERANTZ LLP
Jeremy A. Lieberman
J. Alexander Hood II
600 Third Avenue, 20th Floor
New York, New York 10016
Tel: (212) 661-1100
Fax: (212) 661-8665
jalieberman@pomlaw.com
ahood@pomlaw.com
Plaintiffs’ Lead Counsel
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
STIPULATED PROTECTIVE ORDER
NO. C16-1069 RSM
-11-
CRAVATH, SWAINE AND MOORE LLP
825 Eighth Avenue, New York, NY 10019-7475
Tel: (212) 474-1000 • Fax: (212) 474-3700
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?